Volume 12, Number 1, Janvier-Février 2005
|Page(s)||51 - 55|
|Published online||15 January 2005|
CLA et syndrome lipoatrophique chez la souris
Physiologie de la nutrition, Ecole nationale supérieure de biologie, appliquée à la nutrition et à l’alimentation (ENSBANA), UMR 5170 CNRS/INRA/UB, 1, Esplanade Erasme, 21000
2 U465 Inserm, Centre de recherche des Cordeliers Université Pierre et Marie Curie F-75005 Paris
Conjugated linoleic acid (CLA) refers to a class of positional and geometric dienoic isomers of linoleic acid. Chronic dietary supplementation with a commercial mixture containing c9,t11-CLA and t10,c12-CLA in equimolar quantity leads to a drop in fat mass in various species. The t10,c12-CLA isomer is responsible for this anti-obesity effect. The reduction of fat mass is especially dramatic in the mouse, in which it is associated with a severe hyperinsulinemia, an insulin resistance and a massive liver steatosis. The origin of these adverse side effects and the putative chronology of events leading to CLA-mediated lipoatrophic syndrome are presented and discussed in this review.
Key words: conjugated linoleic acid / lipoatrophy / insulin resistance / β-cell hyperplasia / liver steatosis
© John Libbey Eurotext 2005
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.